Dan Spira
Director/Board Member bei NEXT SCIENCE LIMITED
Vermögen: 159 483 $ am 31.03.2024
Profil
Dan Spira is currently the Group Chief Executive Officer at iNova Pharmaceuticals (Australia) Pty Ltd.
and an Independent Non-Executive Director at Next Science Ltd.
He previously worked as the Chief Marketing Officer, VP & Country Manager at Johnson & Johnson and as the Vice President & General Manager-North America at Bausch Health Cos., Inc. Mr. Spira completed his undergraduate degree at The University of New South Wales.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NEXT SCIENCE LTD
0,26% | 31.12.2022 | 752 172 ( 0,26% ) | 159 483 $ | 31.03.2024 |
Aktive Positionen von Dan Spira
Unternehmen | Position | Beginn |
---|---|---|
NEXT SCIENCE LIMITED | Director/Board Member | 01.06.2017 |
iNova Pharmaceuticals (Australia) Pty Ltd.
iNova Pharmaceuticals (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology iNova Pharmaceuticals Pty Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Australia. | Chief Executive Officer | 01.10.2017 |
Ehemalige bekannte Positionen von Dan Spira
Unternehmen | Position | Ende |
---|---|---|
BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | 01.01.2015 |
JOHNSON & JOHNSON | Sales & Marketing | - |
Ausbildung von Dan Spira
The University of New South Wales | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
BAUSCH HEALTH COMPANIES INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Next Science Ltd. | |
iNova Pharmaceuticals (Australia) Pty Ltd.
iNova Pharmaceuticals (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology iNova Pharmaceuticals Pty Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Australia. | Health Technology |